Veterinary Point-Of-Care (POC) Hematology Diagnostics Global Market Report 2025

The veterinary point-of-care (POC) hematology diagnostics market size is expected to see rapid growth in the next few years. It will grow to $2.6 billion in 2029 at a compound annual growth rate (CAGR) of 13%. This projected growth is driven by increasing adoption of pet insurance, a greater focus on livestock monitoring, rising investments in veterinary care, rising adoption of portable testing equipment, and a growing interest in less invasive diagnostic methods. Key trends expected to shape the market include innovations in diagnostic tools, greater use of integrated technologies in POC devices, the application of artificial intelligence in diagnostics, growing integration with telemedicine services, and a transition toward customized veterinary care.

The rise in pet ownership is anticipated to drive the growth of the veterinary point-of-care (POC) hematology diagnostics market. Pet ownership involves caring for domesticated animals such as dogs, cats, birds, or other pets by meeting their basic needs, ensuring their well-being, and maintaining their overall welfare. This increase is largely due to growing urbanization, with more people in cities seeking companionship and emotional support from pets in smaller, often isolated living environments. Veterinary POC hematology diagnostics supports pet ownership by enabling rapid, on-site blood analysis, which allows for faster diagnoses, timely treatments, and better health outcomes for companion animals. For example, in 2024, Shelter Animals Count, a US-based non-profit organization, reported that total dog and cat adoptions reached 4,192,443, including 2 million dogs and 2 million cats - an increase of 0.4% or 17,153 more adoptions compared to 2023. As a result, the growing number of pet adoptions is contributing to the expansion of the veterinary POC hematology diagnostics market.

Leading companies in the veterinary point-of-care (POC) hematology diagnostics market are focusing on product innovation, particularly the development of veterinary analyzers, to enhance diagnostic precision and efficiency in clinical environments. Veterinary analyzers are diagnostic devices used in animal healthcare to examine biological samples such as blood, urine, or serum. These devices support veterinarians in diagnosing, monitoring, and managing various animal health conditions by delivering fast and accurate results. For instance, in August 2023, Seamaty Diagnostic Co., Ltd., a China-based medical equipment manufacturer, introduced four advanced veterinary analyzers aimed at providing rapid and precise on-site diagnostics, thereby improving the efficiency and care quality in pet hospitals. These include the VG2 vet blood gas electrolyte immunoassay analyzer, which delivers combined blood gas and immunoassay testing; the VG1 veterinary blood gas & electrolyte analyzer, a portable solution for critical care monitoring; the Vi1 veterinary fluorescence immunoassay analyzer, which uses advanced nanocrystal technology for enhanced sensitivity; and the VBC30/VBC50 hematology analyzers, which offer detailed blood counts critical for early disease detection.

In June 2023, Mars Inc., a US-based pet care company, acquired Heska Corp. for $1.3 billion. This acquisition was aimed at bolstering Mars’ position in the animal diagnostics sector by incorporating Heska’s advanced veterinary diagnostic technologies into its science and diagnostics division, thereby meeting the increasing demand for pet healthcare driven by rising pet ownership. Heska Corp. is a US-based veterinary services firm that specializes in manufacturing advanced veterinary diagnostics, including point-of-care (POC) hematology diagnostics.

Major players in the veterinary point-of-care (poc) hematology diagnostics market are Zoetis Inc., IDEXX Laboratories, Sysmex Corp., Bio-Rad Laboratories Inc., HORIBA Medical, Carestream Health Inc., Virbac, Randox Laboratories Ltd., ESAOTE SPA, FUJIFILM SonoSite, Heska Corporation, Getein Animal Medical Technology, Boule Diagnostics AB, Genrui Biotech Inc., Drucker Diagnostics, Volition, Woodley Equipment Company Ltd, Eurolyser Diagnostica GmbH, Hoëk Labs, Bioevopeak.

North America was the largest region in the veterinary point-of-care (POC) hematology diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in veterinary point-of-care (POC) hematology diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the veterinary point-of-care (POC) hematology diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The veterinary point-of-care (POC) hematology diagnostics market includes revenues earned by providing services such as remote monitoring and connectivity, data analysis and reporting, quality control and proficiency testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary point-of-care (POC) hematology diagnostics market also consists of sales of portable handheld analyzers, compact benchtop analyzers, and microfluidic cartridge-based modules. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Veterinary point-of-care (POC) hematology diagnostics refer to fast, on-site testing methods used by veterinarians to assess various blood parameters in animals. These include measurements such as red and white blood cell counts, hemoglobin levels, hematocrit, and platelet counts, all conducted directly at the location of care - such as animal clinics, farms, or shelters. These diagnostic tools support quicker decision-making, speed up treatment processes, and enhance patient outcomes by eliminating the need to send samples to outside laboratories.

The primary product categories in veterinary POC hematology diagnostics are instruments and consumables. Instruments are advanced diagnostic machines used in veterinary settings to efficiently analyze blood samples and assist in prompt diagnosis and treatment. These technologies are applied across a variety of animal groups, including companion animals, livestock, and other animal types. Common applications include detecting blood-related conditions, metabolic diseases, and other disorders. The main end-users of these diagnostics are veterinary hospitals, veterinary clinics, research labs, and other facilities.

The veterinary point-of-care (POC) hematology diagnostics market size has grown rapidly in recent years. It will grow from $1.41 billion in 2024 to $1.6 billion in 2025 at a compound annual growth rate (CAGR) of 13.1%. The growth in the historic period can be attributed to increasing pet ownership, rising demand for companion animal health services, growth in veterinary clinics, increasing awareness of animal health, and rising demand for rapid diagnostic results.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.